Mats Martinell
Overview
Explore the profile of Mats Martinell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
1133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marchiori M, Maguolo A, Perfilyev A, Maziarz M, Martinell M, Gomez M, et al.
Diabetes
. 2024 Dec;
74(3):439-450.
PMID: 39715581
Article Highlights: There is an increasing need for new biomarkers to improve the prediction and prevention of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D), a leading...
2.
Ottesen H, Alvesson H, Idevall Hagren J, Martinell M, Matta L, McAleenan P, et al.
BMJ Open
. 2024 Nov;
14(11):e090448.
PMID: 39609015
Objectives: Cardiometabolic diseases are a global health concern, affecting socioeconomically disadvantaged groups more adversely. Effective public health interventions targeting preventable risk factors like physical inactivity and unhealthy diets are needed....
3.
Kennedy B, Varotsis G, Hammar U, Nguyen D, Carrasquilla G, van Zoest V, et al.
Eur J Public Health
. 2023 Nov;
34(1):14-21.
PMID: 38011903
Background: Diagnostic testing is essential for disease surveillance and test-trace-isolate efforts. We aimed to investigate if residential area sociodemographic characteristics and test accessibility were associated with Coronavirus Disease 2019 (COVID-19)...
4.
Ekenberg M, Qvarnstrom M, Sundstrom A, Martinell M, Wettermark B
Eur J Clin Pharmacol
. 2023 Oct;
80(1):53-63.
PMID: 37870618
Purpose: This study aims to determine initiation and persistence for patients with type 2 diabetes receiving their first prescription of an antidiabetic agent and the associations with socioeconomic factors. Methods:...
5.
Garcia-Calzon S, Schrader S, Perfilyev A, Martinell M, Ahlqvist E, Ling C
Diabetes Res Clin Pract
. 2023 Jun;
202:110807.
PMID: 37356726
Aims: Despite metformin being used as first-line pharmacological therapy for type 2 diabetes, its underlying mechanisms remain unclear. We aimed to determine whether metformin altered DNA methylation in newly-diagnosed individuals...
6.
van Zoest V, Varotsis G, Menzel U, Wigren A, Kennedy B, Martinell M, et al.
Sci Rep
. 2022 Sep;
12(1):15176.
PMID: 36071066
Previous spatio-temporal COVID-19 prediction models have focused on the prediction of subsequent number of cases, and have shown varying accuracy and lack of high geographical resolution. We aimed to predict...
7.
Schrader S, Perfilyev A, Ahlqvist E, Groop L, Vaag A, Martinell M, et al.
Diabetes Care
. 2022 May;
45(7):1621-1630.
PMID: 35607770
Objective: Type 2 diabetes (T2D) was recently reclassified into severe insulin-deficient diabetes (SIDD), severe insulin-resistant diabetes (SIRD), mild obesity-related diabetes (MOD), and mild age-related diabetes (MARD), which have different risk...
8.
Kennedy B, Fitipaldi H, Hammar U, Maziarz M, Tsereteli N, Oskolkov N, et al.
Nat Commun
. 2022 Apr;
13(1):2110.
PMID: 35449172
The app-based COVID Symptom Study was launched in Sweden in April 2020 to contribute to real-time COVID-19 surveillance. We enrolled 143,531 study participants (≥18 years) who contributed 10.6 million daily...
9.
Rosman J, Eriksson J, Martinell M, Lindholm Olinder A, Leksell J
BMJ Open
. 2022 Mar;
12(3):e053955.
PMID: 35351707
Introduction: The prevalence and costs of type 2 diabetes are increasing worldwide. A cornerstone in the treatment and care of diabetes is supporting each patient in self-management. In Sweden, most...
10.
Martinell M, Andersson T, Mannsverk S, Bergholm J, Ellstrom P, Hill A, et al.
Viruses
. 2022 Mar;
14(3).
PMID: 35336908
We describe a flight-associated infection scenario of seven individuals with a B.1.617.2 (Delta) lineage, harbouring an S:E484Q point mutation. In Sweden, at least 10% of all positive SARS-CoV-2 samples were...